Adapting Traditional Drug Development Methods for Epigenetic Therapies- Peter Staller

Hosted By: Gerald Clarke
Rate this Podcast: 
Be the first!
To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

About this Podcast...

Peter Staller Director of Oncology Research at Epitherapeutics talks to Pharma IQ about the differences between traditional drug development techniques and those required for development of a epigenetic therapy. He also discusses epigenetics as a growing area for finding druggable targets and the maturity of the field.

Have Your Say
Rate this feature and give us your feedback in the comments section below



Crowne Plaza Zurich, Zurich, Switzerland
June 17 - 19, 2018